作者: R. F. Gagel , H. Goepfert , D. L. Callender
DOI: 10.3322/CANJCLIN.46.5.261
关键词:
摘要: A wealth of knowledge regarding the molecular causation thyroid carcinoma has been accumulated over past five years. This information already had a significant impact on management some forms carcinoma. The challenge during next 10 years will be to incorporate newly acquired into diagnostic and therapeutic approaches coordinate use this with time-tested further decrease morbidity mortality from